Directory › Thermo Fisher Scientific (Patheon)

Thermo Fisher Scientific (Patheon) — Ferentino

Ferentino, Italy · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Thermo Fisher Scientific (Patheon)
Name(s) in FDA data
Patheon Italia S.p.A
FEI number(s)
3004110157 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Ferentino, Italy
Records matched
12 FDA inspections · 1 inspection with posted 483 citations
Most recent FDA inspection in dataset
30 Jan 2026 — NAI

Capabilities (from the company's website)

  • Sterile fill-finish
    …sheet Steriles Ferentino is a 14,034 m2 (151,061 ft2) facility specializing in integrated sterile liquid and lyophilized product development and commercial manufacturing, including high potency…
  • Lyophilization
    …ntino is a 14,034 m2 (151,061 ft2) facility specializing in integrated sterile liquid and lyophilized product development and commercial manufacturing, including high potency products and L…
  • Biologics drug substance
    …Specialized Capabilities Sterile Liquid vials (SVP & LVP) Biopharmaceuticals, including: Monoclonal antibodies Other recombinant proteins Monoclonal antibodies Proteins Peptides Sterile Lyophilized…
  • Small molecule
    …clonal antibodies Proteins Peptides Sterile Lyophilized vials Secondary packaging (vials) Small molecules Scale up Blood product High-Potency Capabilities Our Ferentino Facility has high-potency…
  • Highly potent (HPAPI)
    …terile liquid and lyophilized product development and commercial manufacturing, including high potency products and LVP. Specialized Capabilities Sterile Liquid vials (SVP & LVP) Biopharmaceut…
  • Peptides & oligonucleotides
    …ncluding: Monoclonal antibodies Other recombinant proteins Monoclonal antibodies Proteins Peptides Sterile Lyophilized vials Secondary packaging (vials) Small molecules Scale up Blood prod…
  • Clinical trial supply & packaging
    …nant proteins Monoclonal antibodies Proteins Peptides Sterile Lyophilized vials Secondary packaging (vials) Small molecules Scale up Blood product High-Potency Capabilities Our Ferentino Fa…

Taken from the company's web page for this site. Source: https://www.patheon.com/us/en/site-locations/ferentino-it.html, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 30 Jan 2026
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 1306942)

  2. 14 Jun 2022
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 1174972)

  3. 25 Feb 2022
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 1247104)

  4. 21 Sep 2018
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 1066263)

  5. 31 Oct 2016
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 1006748)

  6. 16 Dec 2015
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 955569)

  7. 19 May 2015
    FDA inspection FDA inspection classified OAI

    Official Action Indicated (OAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 926682)

  8. 31 Oct 2013
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 853759)

  9. 21 Jun 2013
    Form 483 observations 6 posted Form 483 citation(s)

    Citation summaries (6)
    • 21 CFR 211.110(a): Control procedures to monitor and validate performance
    • 21 CFR 211.122(d): Labels and labeling stored separately
    • 21 CFR 211.198(a): Complaint Handling Procedure
    • 21 CFR 211.22(d): Procedures not in writing, fully followed
    • 21 CFR 211.67(c): Cleaning/maintenance records not kept
    • 21 CFR 211.84(d)(2): Reports of Analysis (Components)

    Source: FDA Data Dashboard – Citations (FEI 3004110157, inspection ID 841054)

  10. 21 Jun 2013
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 841054)

  11. 11 Nov 2011
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 762598)

  12. 30 May 2011
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Biologics. Project area(s): Blood and Blood Products.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 741229)

  13. 22 Jun 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3004110157, inspection ID 595171)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.